-
Je něco špatně v tomto záznamu ?
The NAv1.7 blocker protoxin II reduces burn injury-induced spinal nociceptive processing
JV. Torres-Pérez, P. Adamek, J. Palecek, M. Vizcaychipi, I. Nagy, A. Varga,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
GACR 15-11138S
Grantová Agentura České Republiky - International
MSMT LQ1604
Ministerstvo Školství, Mládeže a Tělovýchovy - International
MSMT CZ.1.05/1.1.00/02.0109
Ministerstvo Školství, Mládeže a Tělovýchovy - International
GAUK138215
Grantová Agentura, Univerzita Karlova - International
RVO 67985823
Akademie Věd České Republiky - International
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- analgetika terapeutické užití MeSH
- blokátory sodíkových kanálů řízených napětím terapeutické užití MeSH
- bolest farmakoterapie MeSH
- mícha cytologie fyziologie MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- napěťově řízený sodíkový kanál, typ 9 fyziologie MeSH
- nervové receptory fyziologie MeSH
- pavoučí jedy terapeutické užití MeSH
- peptidy terapeutické užití MeSH
- popálení farmakoterapie MeSH
- potkani Sprague-Dawley MeSH
- potkani Wistar MeSH
- protein vázající element responzivní pro cyklický AMP metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Controlling pain in burn-injured patients poses a major clinical challenge. Recent findings suggest that reducing the activity of the voltage-gated sodium channel Nav1.7 in primary sensory neurons could provide improved pain control in burn-injured patients. Here, we report that partial thickness scalding-type burn injury on the rat paw upregulates Nav1.7 expression in primary sensory neurons 3 h following injury. The injury also induces upregulation in phosphorylated cyclic adenosine monophosphate response element-binding protein (p-CREB), a marker for nociceptive activation in primary sensory neurons. The upregulation in p-CREB occurs mainly in Nav1.7-immunopositive neurons and exhibits a peak at 5 min and, following a decline at 30 min, a gradual increase from 1 h post-injury. The Nav1.7 blocker protoxin II (ProTxII) or morphine injected intraperitoneally 15 min before or after the injury significantly reduces burn injury-induced spinal upregulation in phosphorylated serine 10 in histone H3 and phosphorylated extracellular signal-regulated kinase 1/2, which are both markers for spinal nociceptive processing. Further, ProTxII significantly reduces the frequency of spontaneous excitatory post-synaptic currents in spinal dorsal horn neurons following burn injury. Together, these findings indicate that using Nav1.7 blockers should be considered to control pain in burn injury. KEY MESSAGES: • Burn injury upregulates Nav1.7 expression in primary sensory neurons. • Burn injury results in increased activity of Nav1.7-expressing primary sensory neurons. • Inhibiting Nav1.7 by protoxin II reduces spinal nociceptive processing. • Nav1.7 represents a potential target to reduce pain in burn injury.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045592
- 003
- CZ-PrNML
- 005
- 20200115102058.0
- 007
- ta
- 008
- 200109s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00109-017-1599-0 $2 doi
- 035 __
- $a (PubMed)29063143
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Torres-Pérez, Jose Vicente $u Nociception Group, Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.
- 245 14
- $a The NAv1.7 blocker protoxin II reduces burn injury-induced spinal nociceptive processing / $c JV. Torres-Pérez, P. Adamek, J. Palecek, M. Vizcaychipi, I. Nagy, A. Varga,
- 520 9_
- $a Controlling pain in burn-injured patients poses a major clinical challenge. Recent findings suggest that reducing the activity of the voltage-gated sodium channel Nav1.7 in primary sensory neurons could provide improved pain control in burn-injured patients. Here, we report that partial thickness scalding-type burn injury on the rat paw upregulates Nav1.7 expression in primary sensory neurons 3 h following injury. The injury also induces upregulation in phosphorylated cyclic adenosine monophosphate response element-binding protein (p-CREB), a marker for nociceptive activation in primary sensory neurons. The upregulation in p-CREB occurs mainly in Nav1.7-immunopositive neurons and exhibits a peak at 5 min and, following a decline at 30 min, a gradual increase from 1 h post-injury. The Nav1.7 blocker protoxin II (ProTxII) or morphine injected intraperitoneally 15 min before or after the injury significantly reduces burn injury-induced spinal upregulation in phosphorylated serine 10 in histone H3 and phosphorylated extracellular signal-regulated kinase 1/2, which are both markers for spinal nociceptive processing. Further, ProTxII significantly reduces the frequency of spontaneous excitatory post-synaptic currents in spinal dorsal horn neurons following burn injury. Together, these findings indicate that using Nav1.7 blockers should be considered to control pain in burn injury. KEY MESSAGES: • Burn injury upregulates Nav1.7 expression in primary sensory neurons. • Burn injury results in increased activity of Nav1.7-expressing primary sensory neurons. • Inhibiting Nav1.7 by protoxin II reduces spinal nociceptive processing. • Nav1.7 represents a potential target to reduce pain in burn injury.
- 650 _2
- $a analgetika $x terapeutické užití $7 D000700
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a popálení $x farmakoterapie $7 D002056
- 650 _2
- $a protein vázající element responzivní pro cyklický AMP $x metabolismus $7 D017362
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a napěťově řízený sodíkový kanál, typ 9 $x fyziologie $7 D062556
- 650 _2
- $a bolest $x farmakoterapie $7 D010146
- 650 _2
- $a peptidy $x terapeutické užití $7 D010455
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a nervové receptory $x fyziologie $7 D011984
- 650 _2
- $a pavoučí jedy $x terapeutické užití $7 D013111
- 650 _2
- $a mícha $x cytologie $x fyziologie $7 D013116
- 650 _2
- $a blokátory sodíkových kanálů řízených napětím $x terapeutické užití $7 D061567
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Adamek, Pavel $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic. Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Palecek, Jiri $u Department of Functional Morphology, Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Vizcaychipi, Marcela $u Department of Anaesthetics, Chelsea and Westminster Hospital NHS Trust, 369 Fulham Road, London, SW10 9NH, UK.
- 700 1_
- $a Nagy, Istvan $u Nociception Group, Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. i.nagy@imperial.ac.uk.
- 700 1_
- $a Varga, Angelika $u MTA-DE-NAP B-Pain Control Research Group, Department of Anatomy, Histology and Embryology, University of Debrecen, Debrecen, 4012, Hungary.
- 773 0_
- $w MED00002812 $t Journal of molecular medicine (Berlin, Germany) $x 1432-1440 $g Roč. 96, č. 1 (2018), s. 75-84
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29063143 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115102431 $b ABA008
- 999 __
- $a ok $b bmc $g 1483860 $s 1084265
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 96 $c 1 $d 75-84 $e 20171023 $i 1432-1440 $m Journal of molecular medicine $n J Mol Med $x MED00002812
- GRA __
- $a GACR 15-11138S $p Grantová Agentura České Republiky $2 International
- GRA __
- $a MSMT LQ1604 $p Ministerstvo Školství, Mládeže a Tělovýchovy $2 International
- GRA __
- $a MSMT CZ.1.05/1.1.00/02.0109 $p Ministerstvo Školství, Mládeže a Tělovýchovy $2 International
- GRA __
- $a GAUK138215 $p Grantová Agentura, Univerzita Karlova $2 International
- GRA __
- $a RVO 67985823 $p Akademie Věd České Republiky $2 International
- LZP __
- $a Pubmed-20200109